Variable | OR | 95% CI | p-value |
---|---|---|---|
Age (years) | |||
50–59a | Reference | ||
60–69 | 1.43 | (0.30, 6.74) | 0.652 |
70–79 | 1.14 | (0.26, 5.09) | 0.861 |
≥ 80 | 5.71 | (0.52, 62.66) | 0.154 |
BMI (kg/m2) | 0.77 | (0.64, 0.91) | 0.003* |
Underweight (BMI < 18.5) | 8.84 | (1.06, 74.03) | 0.044* |
Normal weight (BMI 18.5–24.9a) | Reference | ||
Overweight (BMI ≥ 25) | 0.62 | (0.16, 2.44) | 0.498 |
Tobacco use (Pack-years) | 1.01 | (0.99, 1.03) | 0.359 |
Charlson comorbidity index | 1.18 | (0.73, 1.91) | 0.507 |
Inhaled corticosteroid uses in the past year | 0.83 | (0.08, 8.55) | 0.878 |
Oral corticosteroid uses in the past year | 1.19 | (0.38, 3.69) | 0.766 |
GOLD grade | |||
Grade Ia | Reference | ||
Grade II | 1.20 | (0.28, 5.07) | 0.804 |
Grade III | 1.37 | (0.27, 6.87) | 0.701 |
Grade IV | 1.00 | (0, 1.00) | 0.999 |
COPD Assessment Test (CAT™) score | 1.02 | (0.96, 1.09) | 0.469 |
Numbers of exacerbation in previous year | 1.00 | (0.86, 1.17) | 0.952 |
FFMI (kg/m2) | 0.63 | (0.44, 0.89) | 0.009* |
< 17 | 4.91 | (1.26, 19.06) | 0.022* |
≥ 17a | Reference |